Loading the lesson
Loading the lesson
Search AllRounder.ai
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Search the courses, subjects, tracks, games and features, or jump straight to a page.
Learn it your way
A short class with Sarah and her students. The other ways are under More.
Sign up free to listen. Transcripts are free to read.
Today we’re going to explore CRISPR-dCas9 fusion proteins. Who can tell me what CRISPR stands for?
Isn't it clustered regularly interspaced short palindromic repeats?
Exactly! CRISPR is a powerful tool for gene editing, and when we talk about dCas9, it refers to a 'dead' version of Cas9 that cannot cut DNA. Can anyone think why a 'cutting' function might not always be necessary?
Maybe because we want to modify gene expression without changing the sequence?
Great point! That leads us to the fusion aspect of these proteins, which allows us to add various epigenetic modifiers. Can anyone name one of these modifiers?
I remember DNMT3A is one of them!
Correct! DNMT3A is used for targeted DNA methylation. Let's summarize: we have a 'dead' Cas9 that can deliver modifiers right where we need them without altering the DNA structure.
Now, let’s delve deeper into how these dCas9 fusions work. Who can describe what happens when dCas9 is fused with DNMT3A?
It adds a methyl group to the target DNA site, which usually represses gene expression.
Exactly! And what about dCas9-TET1?
That one removes methyl groups, right? It promotes gene expression.
Right again! Lastly, dCas9-p300 adds acetyl groups. What effect does that have on chromatin?
It loosens the chromatin structure, making the DNA more accessible for transcription!
Well done! This gives us powerful tools to regulate gene expression based on our needs.
Let’s talk about how CRISPR-dCas9 fusion proteins are being applied in research and medicine. What are some examples you can think of?
They could reactivate silenced tumor suppressor genes in cancer therapy!
Exactly! Reactivating these genes can help in fighting cancer. What about neurological disorders?
They might help to regulate memory-related genes?
Spot on! CRISPR-dCas9 also has potential in studying developmental biology. Can anyone summarize how it works in that field?
By altering specific genes, researchers can understand patterns of cell differentiation.
Great summary! These applications highlight the transformative role of CRISPR-dCas9 in modern biology.
Fusion technology allowing for targeted epigenetic modification without altering DNA.
A protein that attaches methyl groups to DNA, silencing genes.
A protein that removes methyl groups and can activate gene expression.
Acetylates histones to enhance accessibility for transcription.
dCas9 is dead, but don’t you fret, / With modifiers, there's no regret!
Imagine dCas9 as a mailman who doesn’t deliver packages; instead, he directs where the packages should go, helping modify the way houses look without changing their actual walls.
DPT for dCas9: 'D' for dead, 'P' for protein, 'T' for targeting.
Remember 'MT' for Methyl Transferase relating to DNMT3A, as it adds methyl groups.
Term
What is CRISPR?
Click to flip
Term
What does dCas9 do?
Click to flip
Term
What is the role of DNMT3A?
Click to flip
Term
What does TET1 do?
Click to flip
Term
What is p300?
Click to flip
A gene-editing technology that allows for specific modifications to DNA sequences.
A catalytically inactive Cas9 protein that can bind to DNA without cutting it.
An enzyme that adds methyl groups to DNA, usually leading to gene silencing.
An enzyme that removes methyl groups from DNA, promoting gene expression.
A histone acetyltransferase that adds acetyl groups to histones, enhancing gene transcription.
CRISPR-dCas9 fusion proteins enable targeted epigenetic modifications without altering DNA sequences, offering innovative tools for gene regulation.
This section describes CRISPR-dCas9 fusion proteins, which combine dead Cas9 with various epigenetic modifiers. These tools facilitate targeted modifications of epigenetic marks such as DNA methylation and histone acetylation, enhancing our ability to manipulate gene expression for research and therapeutic purposes.
CRISPR-dCas9 fusion proteins represent a revolutionary advancement in the field of epigenetic engineering. These proteins consist of a dead Cas9 (dCas9) fused with various epigenetic modifiers that allow for precise control over gene expression without making permanent changes to the DNA sequence itself. The fusion of dCas9 with factors such as DNMT3A, TET1, and p300 enables researchers to either methylate, demethylate, or acetylate specific genomic regions respectively. These targeted modifications can influence chromatin structure and gene accessibility, providing a powerful toolkit for manipulating gene expression in various biological contexts, including therapeutic applications for diseases such as cancer and neurological disorders.